Vitamin E: Worldwide Market Analysis & Forecast 2018-2023 - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Global Vitamin E market - Growth, Trends, and Forecast (2018 - 2023)" report has been added to ResearchAndMarkets.com's offering.

Global vitamin E market is expected to attain a CAGR of 5.2% during the forecast period (2018-2023) due to rising application scope particularly in the treatment of lifestyle diseases.

The ever-increasing healthcare burden has resulted in the paradigm shift of consumers to dietary supplements and value added food products rather than accessing nutrients from traditional diets. This growing demand for value-added nutritive foods coupled with the increasing prevalence of lifestyle diseases is expected to drive the global vitamin E market.

Vitamin E has been scientifically proven to protect the body from cell damaging free radicals thereby avoiding the buildup of reactive oxygen species (ROS) that are oxidized products. Thus, the role of Vitamin E in preventing or delaying chronic diseases associated with free radicals is providing the further push to the market.

Aging and geriatric population are increasingly preferring vitamin E supplements as a preventive medicaments and this has led to the annual growth of more than 3% of global Vitamin E supplements market from 2014 to 2017.

Key Topics Covered

1. Introduction

2. Market Insights

3. Market Dynamics

4. Market Segmentation

5. Regional Market Analysis

6. Competitive Landscape

7. Company Profiles

  • BASF SE
  • DSM Nutritional Products
  • Eisai Food & Chemical Co. Ltd.
  • Soham Organics Pvt. Ltd.
  • DSM NV
  • Archer Daniels Midland Company
  • Davos Life Science Pvt. Ltd.
  • Fenchem Biotek Ltd.
  • Wilmar International
  • Cargill
  • American River Nutrition Ltd.
  • Nutralliance

For more information about this report visit https://www.researchandmarkets.com/research/phsmjv/vitamin_e'w=4

» Publication Date: 09/08/2018

» More Information

« Go to Technological Watch



This project has received funding from the Bio-Based Industries Joint Undertaking under the European Union’s Horizon 2020 research and innovation programme under grant agreement Nº 745828